Sarepta Therapeutics SRPT
NASDAQ SRPT
$17.57 -0.65 (-3.57%)
At close: Oct 1, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) Cash from Financing Activities (2010 - 2026)

Updated

Sarepta Therapeutics (SRPT) posted Cash from Financing Activities of $241,000 for Q1 2026, down 98.1% from $12.47 million a year earlier.

Analysis

Sarepta Therapeutics (SRPT) Cash from Financing Activities (2010 - 2026) Analysis & Trends

For FY2025, Sarepta Therapeutics' Cash from Financing Activities came in at -$168.34 million.

  • In prior years, Sarepta Therapeutics' Cash from Financing Activities was $124.81 million in FY2024 (-0.2%), $125 million in FY2023 (-46.2%), $232.51 million in FY2022 (-58.6%) and $561.57 million in FY2021 (-17.7%).
  • Quarterly Cash from Financing Activities has run from a low of -$117.79 million in Q3 2025 to a high of $549.25 million in Q4 2021 over five years.
  • On a year-over-year basis, Cash from Financing Activities increased in 1 of the last four quarters, with growth averaging 107.2%.
  • The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q2 2024, with growth of 581.1%; the weakest was Q1 2026, with a decline of 98.1%.
  • According to Business Quant data, Cash from Financing Activities for the three prior quarters was -$39.21 million (Q4 2025), -$117.79 million (Q3 2025) and -$23.82 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Sarepta Therapeutics 1.92 Bn -1.31 Bn 251.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 241,000.00
Dec 31, 2025 -39.21 Mn
Sep 30, 2025 -117.79 Mn
Jun 30, 2025 -23.82 Mn
Mar 31, 2025 12.47 Mn
Dec 31, 2024 48.99 Mn
Sep 30, 2024 13.76 Mn
Jun 30, 2024 39.92 Mn
Mar 31, 2024 22.14 Mn
Dec 31, 2023 1.94 Mn
Sep 30, 2023 15.41 Mn
Jun 30, 2023 5.86 Mn
Mar 31, 2023 101.80 Mn
Dec 31, 2022 10.75 Mn
Sep 30, 2022 216.43 Mn
Jun 30, 2022 339,000.00
Mar 31, 2022 4.99 Mn
Dec 31, 2021 549.25 Mn
Sep 30, 2021 5.90 Mn
Jun 30, 2021 3.53 Mn
API Access

Sarepta Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=SRPT&period=max&api_key=YOUR_API_KEY